tool

The study provides a more accurate tool for stratifying patients with HER2-positive breast cancer

The study provides a more accurate tool for stratifying patients with HER2-positive breast cancer

Patients with a type of breast cancer called HER2-positive have a lower chance of survival if their initial treatment fails to completely eradicate the tumor and they have high levels of tumor-infiltrating immune cells called lymphocytes in the residual disease. Dr Federica Miglietta said on the 13thThursday European Breast Cancer Conference that normally tumor-infiltrating lymphocytes …

The study provides a more accurate tool for stratifying patients with HER2-positive breast cancer Read More »

ctDNA has been shown to be effective as a treatment decision tool for adjuvant chemotherapy in colon cancer

ctDNA has been shown to be effective as a treatment decision tool for adjuvant chemotherapy in colon cancer

Controlled approaches using circulating tumor DNA can reduce the number of patients receiving adjuvant chemotherapy without the risk of reducing recurrence-free survival in some patients with stage II colon cancer. Controlled approaches using circulating tumor DNA (ctDNA) may, according to the DYNAMIC Phase 2 study, reduce the number of patients receiving adjuvant chemotherapy without the …

ctDNA has been shown to be effective as a treatment decision tool for adjuvant chemotherapy in colon cancer Read More »